Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1767-2025

Baxter Novum IQ LVP INFUSION SYSTEM, REF 40700BAXUS Recall

Baxter Novum IQ LVP INFUSION SYSTEM, REF 40700BAXUS

FDA recall Class I

Ongoing

FDA lists this Class I recall for Baxter Novum IQ LVP INFUSION SYSTEM, REF 40700BAXUS. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1767-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Apr 24, 2025
FDA report date
May 28, 2025
Quantity in commerce
34,524 units
Distribution
See key details
FDA cause
Device Design

What is being recalled?

Baxter Novum IQ LVP INFUSION SYSTEM, REF 40700BAXUS

Affected model & UDI checker

Search the exact identifiers published for Z-1767-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
40700BAXUSBaxter Novum IQ LVP INFUSION SYSTEM, REF 40700BAXUSCheck source noticeNot specified
FDA code information

All serial numbers

View the original FDA recall notice

Why was this product recalled?

There is a potential for the Novum IQ LVP due to the potential for underinfusion following use of the "standby mode" feature or if the device is powered off with the set loaded.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Baxter Healthcare Corporation take?

Baxter issued an URGENT MEDICAL DEVICE CORRECTION notice to its consignees on 04/24/2025 via USPS First Class Mail. The notice explained the issue, hazard, and requested the following: Actions to be Taken by Customers 1. For flow rates greater than 50 mL/hour, do not exceed a programmed standby time of 2 hours and 30 minutes. Monitor patients frequently to ensure that the appropriate infusion is being delivered. 2. Please remove the set upon powering off the device. 3. Post the enclosed informational poster with Novum IQ LVPs in your facility. 4. Acknowledge receipt of this notification by following the instructions on the enclosed reply instruction sheet, even if you have no remaining inventory. Acknowledging receipt will prevent you from receiving repeat notices. If you do not complete the acknowledgement, you will receive a phone call from OnProcess Technology on behalf of Baxter to confirm your receipt of this notification. 5. Please forward a copy of this communication to the Chief Medical Officer, Medical Director, Director of Nursing, Director of Pharmacy, Facility Risk Manager, Director of Purchasing/Central Supply, and any other departments within your institution who use the affected product. For general questions regarding this communication, or if you experience quality problems, please contact your Baxter sales representative, or Baxter Global Technical Services at 800-843-7867 (select option 2, then option 2 again) Monday through Friday, between 7:00 am and 7:00 pm Eastern Time.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology